DRW Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,500
Closed -$485K 1358
2025
Q3
$485K Buy
+1,500
New +$467K 0.01% 630
2024
Q3
Sell
-6,200
Closed -$3.36M 611
2024
Q2
$3.36M Buy
+6,200
New +$3.28M 0.13% 111
2017
Q1
Sell
-10,000
Closed -$1.44M 78
2016
Q4
$1.44M Hold
10,000
0.11% 29
2016
Q3
$1.25M Buy
+10,000
New +$1.29M 0.09% 34

Other funds holding ELV

DRW Securities's ELV Position: Q1 2026 in Review

DRW Securities sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 732 shares — an estimated $252K sold.

DRW Securities first reported a position in ELV in Q4 2017 and held it in 12 quarters. The position peaked at $1.56M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • DRW Securities reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 732 Elevance Health shares in Q1 2026, an estimated $252K.
  • DRW Securities first reported a position in Elevance Health in Q4 2017 and held it in 12 quarters.
  • DRW Securities's Elevance Health position peaked at $1.56M in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.